Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Osteonecrosis of the maxilla and mandible in patients with metastatic breast cancer
    Meeting Abstract

    Van Poznak, C. H.; Estilo, C. L.; Williams, T.; Sauter, N.; Hudis, C.; Tunick, S.; Huryn, J. M.; Halpern, J.
    Journal of Bone and Mineral Research (2004)

    Fulltext@MSK | Save
  • Osteonecrosis of the jaw in patients with metastatic breast cancer
    Meeting Abstract

    Van Poznak, C. H.; Estilo, C. L.; Sauter, N. P.; Hudis, C. A.; Williams, T.; Tunick, S.; Halpern, J.; Huryn, J. M.
    Breast Cancer Research and Treatment (2004)

    Fulltext@MSK | Save
  • Long-term intravenous bisphosphonate use: A case report
    Meeting Abstract

    Van Poznak, C.; Moynahan, M. E.; Hudis, C.
    Journal of Bone and Mineral Research (2004)

    Fulltext@MSK | Save
  • Human breast cancers express osteoprotegerin (OPG), tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and receptor activator of nFkB ligand (RANKL)
    Meeting Abstract

    Van Poznak, C.; Cross, S. S.; Saggese, M.; Lippitt, J. M.; Hudis, C.; Coleman, R. E.; Holen, I.
    Bone (2004)

    Fulltext@MSK | Save
  • 17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison
    Meeting Abstract

    Tse, A. N.; Solit, D.; Rosen, N.; Schwartz, G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygaidanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Valentin, G.; Delacruz, A.; Ye, Q.; Schwartz, L.; Larson, S.; Rosen, N.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • MSKCC Quality Assessment (QA) monitoring program for potentially harmful chemotherapy orders
    Meeting Abstract

    Sklarin, N. T.; Timoney, J.; Kampel, L.; Hydzik, C.; Savage, J.; Capobianco, M.; Miransky, J.; Haspel, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • TP53 and CHEK2*1100delC gene mutation in North American families suggestive Li-Fraumeni syndrome: Memorial Sloan-Kettering experience
    Meeting Abstract

    Siddiqui, R.; Diaz, L. R.; Nafa, K.; Kauff, N.; Facio, F.; Huang, H.; Onel, K.; Robson, M.; Ellis, N.; Offit, K.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • CALGB 9840: Phase III study of weekly (W) paclitaxel (P) via 1-hour(h) infusion versus standard (S) 3h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC
    Meeting Abstract

    Seidman, A. D.; Berry, D.; Cirrincione, C.; Harris, L.; Dressler, L.; Muss, H.; Norton, L.; Winer, E.; Hudis, C.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Feasibility of breast conserving treatment for breast cancer in women with germline BRCA mutations: A clinic-based series
    Meeting Abstract

    Robson, M.; Holcombe, T.; McCormick, B.; Borgen, P.; Gulati, T.; Jhanwar, S.; Kauff, N.; Hudis, C.; Norton, L.; Offit, K.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save